Goals

This will lead to more accurate genotyping, prediction, early assessment of response, and minimal residual disease.


go to main content
Research Research programs Precision medicine in patients with solid cancer:

Our purpose

We aim to improve outcome for patients with solid cancer, particular for targeted- and immunotherapies, by use of more accurate and novel molecular diagnostics.

Goals

See some of the most important goals for this research program.

read more

Research groups contributing to this research program

Cancer pharmacology

Nielka van Erp's research group focuses on describing, explaining, understanding and modifying the pharmacokinetics of oral anticancer drugs.

Experimental urology

Jack Schalken's research group focuses on preclinical models for cancer, precision medicine by molecular diagnostics, with a focus on prognostic- and predcitive biomarkers and on GU oncology and salivary gland cancer.

Genetic epidemiology

Sita Vermeulen's research group aims to understand underlying mechanisms of prognosis and treatment response in order to facilitate personalized medicine. The group mainly uses molecular epidemiological studies and has a focus on bladder cancer.

Spokesperson(s) for this research program

Spokesperson

dr. Niven Mehra

contact form